Drawing for SPHERIX

USPTO serial 99414420

SPHERIX

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
ALLEN, BIANCA LEIGH
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPHERIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Megan Clifford

Megan Clifford Troutman Pepper Locke LLPChurch Street Station; P.O. Box 1470New York, NY 10008-1470United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable reports, presentations, dashboards, and data visualizations featuring data and analysis in the fields of medical science, pharmaceuticals, biotechnology, MedTech, finance, healthcare, media agencies, and market research.ACTIVE—
035Market research and intelligence services in the fields of medical science, pharmaceuticals, biotechnology, MedTech, finance, healthcare, and media agencies, across specialty therapeutic areas; Collection and analysis of market insights from healthcare professionals, patients, payers, and industry stakeholders; Preparation of market analysis reports and strategic advisory materials; Business consulting in the areas of competitive intelligence, brand strategy, and healthcare market accessACTIVE—
042Medical science consultancy services, namely compiling data for research purposes in the field of medical science and providing guidance and strategies across specialty therapeutic areas; Software as a service (SAAS) services featuring software and data visualizations for online market research tools to automate survey data collection and creation triggered by market events and trends, for use by pharmaceutical manufacturers in planning, evaluating, and executing marketing strategies.ACTIVE—
044Advisory services relating to healthcare, namely, advisory in the field of medical science, specialty therapeutic areas in dermatology, gastroenterology, rheumatology, nephrology, ophthalmology, hematology, and oncology, and pharmaceutical and biotechnology manufacturing.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 17, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jun 17, 2026CNSLSUSPENSION LETTER WRITTEN—
May 15, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 15, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 15, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 15, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 15, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 15, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 15, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 15, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2026DOCKASSIGNED TO EXAMINER—
Feb 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 26, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance